Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts

  • liuxq
    started a topic several questions about tophat and cufflinks

    several questions about tophat and cufflinks

    1. for paired-end rna seq reads, how does --mate-inner-dist and --mate-std-dev affect the tophat mapping result? According to my understanding, these two parameters should only affect the second column of sam/bam output.

    2. for cufflinks package, why cufflinks and cuffdiff give inconsistent fpkm value for some transcripts? Below is my command to run cufflinks and cuffdiff
    Cufflinks -G ensembl_hg19.gtf t1_tophat_hits.bam
    cuffdiff -p 20 --total-hits-norm ensembl_hg19.gtf r1_tophat_hits.bam r2_tophat_hits.bam

    3. if a particular loci has several isoforms, for example iso1,iso2,..., iso5, but the sample sequenced only contains two of the five isoforms, such as iso1 and iso2. If I use gtf file conteining all 5 isoforms annotation to run cufflinks, whether the nonexistent three isoforms will affect the expression abundance estimation for actually existent isoforms (iso1 and iso2)? Can cufflinks give 0 fpkm for these 3 nonexistent isoforms?

    Thanks in advance and look forward to your response.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    Today, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 05:39 AM
0 responses
10 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 09:56 AM
0 responses
12 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-09-2026, 11:14 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 09-29-2026, 09:51 AM
0 responses
77 views
0 reactions
Last Post SEQadmin2  
Working...